What is the Impact Factor of Infection and Drug Resistance?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Infection and Drug Resistance is 3.20, ranking in quartile Q2 of Web of Science (SCIE).

Is Infection and Drug Resistance indexed in Web of Science or Scopus?

Yes, Infection and Drug Resistance is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.791 (Q2) and an H-index of 83.

Who publishes Infection and Drug Resistance and what is the Article Processing Charge (APC)?

Infection and Drug Resistance is published by Dove Medical Press Ltd.. The estimated Article Processing Charge (APC) is approximately $3,211 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Infection and Drug Resistance?

The official ISO-4 abbreviation of Infection and Drug Resistance is "INFECT DRUG RESIST". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #7,024Hybrid

Infection and Drug Resistance

Abbreviation (ISO):INFECT DRUG RESIST

•

Identifier (ISSN):1178-6973(Print)

•

Publisher:Dove Medical Press Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

3.2↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Infection and Drug Resistance

WoS Q2

Annual Impact Factor Metric

Current (2026):3.2

Scopus SJR & RankScopus Q2

0.791

#7,024

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

83 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate6.9%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

529articles/year

99.5% Gold OA•90.52% Original Research

Aims & Scope

About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.

Topics Covered (Recognized by AI)

Biology88.5%Medicine79.1%Genetics77.9%Chemistry70.3%Biochemistry68.1%Microbiology63.2%Internal medicine55.1%Geology49.1%Paleontology49%Antibiotics48.7%Bacteria46.2%Pathology45.6%Gene38.8%Immunology29.7%Surgery27.5%Organic chemistry26.6%Antibiotic resistance22.4%Escherichia coli22.1%Antimicrobial21.4%Virology20.7%

Primary Research Areas

Medicine Pharmacology (medical)

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

INFECTIOUS DISEASES

Rank55/141

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank156/356

IndexSCIE

JCISCIE2026

INFECTIOUS DISEASES

Rank61/141

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank135/356

IndexSCIE

Category	Index	Rank	Quartile
INFECTIOUS DISEASES	JCRSCIE	55/141	Q2
PHARMACOLOGY & PHARMACY	JCRSCIE	156/356	Q2
INFECTIOUS DISEASES	JCISCIE	61/141	Q2
PHARMACOLOGY & PHARMACY	JCISCIE	135/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.2

Articles / Year527

Total Citations137

2025

IF2.9

Articles / Year599

Total Citations1,673

2024

IF2.9

Articles / Year563

Total Citations2,893

2023

IF3.9

Articles / Year705

Total Citations7,999

2022

IF4.177

Articles / Year735

Total Citations9,942

Year	Impact Factor	Articles / Year	Total Citations
2026	3.2	527	137
2025	2.9	599	1,673
2024	2.9	563	2,893
2023	3.9	705	7,999
2022	4.177	735	9,942
2021	4.003	551	12,237
2020	2.984	470	14,891
2019	3	384	12,871
2018	3.443	274	12,167
2017	—	64	3,175
2016	—	35	1,357
2015	—	39	2,967

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,024Scopus Q2SCImago Profile

Scopus Coverage:2009-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.791

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

3.19

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,211 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations6,581

3-Year Documents1,977

Citable Documents1,908

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ2

PharmacologyQ2

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 6.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区INFECTIOUS DISEASES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Infection and Drug Resistance (abbr: INFECT DRUG RESIST, ISSN: 1178-6973) is a peer-reviewed international scholarly journal in the field of Medicine, published by Dove Medical Press Ltd. in United States. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.791 (Q2), an H-index of 83.

The journal enforces rigorous peer evaluation with an annual output of approximately 529 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,211 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.